Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress

1:30 PM - 2:45 PM (PDT), Tuesday, June 9, 2020
Search General Info
Search Education
Search Partnering Companies
Gene therapies are transforming patients’ lives in ways that were unimaginable twenty years ago. With recent scientific advances commercial gene therapies have been met with exciting opportunities for treatment for previously untreatable genetic diseases. With these advances come challenges and opportunities in scientific discovery and new approaches to developing and delivering genetic medicines. Gain insights and perspectives from stakeholders with experience tackling these challenges while bringing new types of treatments to patients. Find out what progress has been made since BIO 2019 and what is on the horizon for this exciting field.

Sponsored by Pfizer Inc.
Sponsored By
Moderator
photo
Senior Vice President, Global Gene Therapy Business, Rare Disease, Global Innovation Pharma
Pfizer, Inc.
Speakers
photo
Visiting Professor; Co-founder and Former President and Head of R&D
Rockefeller University; Spark Therapeutics
Natalie Holles
President and Chief Executive Officer
Audentes, an Astellas Company
photo
Managing Director, Healthcare, Investment Banking
Morgan Stanley
Peter Marks
Director, Centers for Biologics Evaluation & Research
US Food & Drug Administration
photo
Chief Executive Officer & Founder
CureDuchenne
photo
Senior Vice President, Global Gene Therapy Business, Rare Disease, Global Innovation Pharma
Pfizer, Inc.